These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 32631568

  • 1. Structural studies of triazole inhibitors with promising inhibitor effects against antibiotic resistance metallo-β-lactamases.
    Muhammad Z, Skagseth S, Boomgaren M, Akhter S, Fröhlich C, Ismael A, Christopeit T, Bayer A, Leiros HS.
    Bioorg Med Chem; 2020 Aug 01; 28(15):115598. PubMed ID: 32631568
    [Abstract] [Full Text] [Related]

  • 2. 4-Amino-1,2,4-triazole-3-thione-derived Schiff bases as metallo-β-lactamase inhibitors.
    Gavara L, Sevaille L, De Luca F, Mercuri P, Bebrone C, Feller G, Legru A, Cerboni G, Tanfoni S, Baud D, Cutolo G, Bestgen B, Chelini G, Verdirosa F, Sannio F, Pozzi C, Benvenuti M, Kwapien K, Fischer M, Becker K, Frère JM, Mangani S, Gresh N, Berthomieu D, Galleni M, Docquier JD, Hernandez JF.
    Eur J Med Chem; 2020 Dec 15; 208():112720. PubMed ID: 32937203
    [Abstract] [Full Text] [Related]

  • 3. Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance.
    Wachino JI, Jin W, Kimura K, Kurosaki H, Sato A, Arakawa Y.
    mBio; 2020 Mar 17; 11(2):. PubMed ID: 32184250
    [Abstract] [Full Text] [Related]

  • 4. Metallo-β-lactamase inhibitors by bioisosteric replacement: Preparation, activity and binding.
    Skagseth S, Akhter S, Paulsen MH, Muhammad Z, Lauksund S, Samuelsen Ø, Leiros HS, Bayer A.
    Eur J Med Chem; 2017 Jul 28; 135():159-173. PubMed ID: 28445786
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and Preclinical Evaluation of TPA-Based Zinc Chelators as Metallo-β-lactamase Inhibitors.
    Schnaars C, Kildahl-Andersen G, Prandina A, Popal R, Radix S, Le Borgne M, Gjøen T, Andresen AMS, Heikal A, Økstad OA, Fröhlich C, Samuelsen Ø, Lauksund S, Jordheim LP, Rongved P, Åstrand OAH.
    ACS Infect Dis; 2018 Sep 14; 4(9):1407-1422. PubMed ID: 30022668
    [Abstract] [Full Text] [Related]

  • 6. Discovery of [1,2,4]Triazole Derivatives as New Metallo-β-Lactamase Inhibitors.
    Yuan C, Yan J, Song C, Yang F, Li C, Wang C, Su H, Chen W, Wang L, Wang Z, Qian S, Yang L.
    Molecules; 2019 Dec 23; 25(1):. PubMed ID: 31877988
    [Abstract] [Full Text] [Related]

  • 7. 4-Alkyl-1,2,4-triazole-3-thione analogues as metallo-β-lactamase inhibitors.
    Gavara L, Legru A, Verdirosa F, Sevaille L, Nauton L, Corsica G, Mercuri PS, Sannio F, Feller G, Coulon R, De Luca F, Cerboni G, Tanfoni S, Chelini G, Galleni M, Docquier JD, Hernandez JF.
    Bioorg Chem; 2021 Aug 23; 113():105024. PubMed ID: 34116340
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of aspergillomarasmine A/meropenem combinations with and without avibactam against bacterial strains producing multiple β-lactamases.
    Rotondo CM, Wright GD.
    Antimicrob Agents Chemother; 2024 Sep 04; 68(9):e0027224. PubMed ID: 39133022
    [Abstract] [Full Text] [Related]

  • 9. Cyclic Boronates Inhibit All Classes of β-Lactamases.
    Cahill ST, Cain R, Wang DY, Lohans CT, Wareham DW, Oswin HP, Mohammed J, Spencer J, Fishwick CW, McDonough MA, Schofield CJ, Brem J.
    Antimicrob Agents Chemother; 2017 Apr 04; 61(4):. PubMed ID: 28115348
    [Abstract] [Full Text] [Related]

  • 10. H2dpa derivatives containing pentadentate ligands: An acyclic adjuvant potentiates meropenem activity in vitro and in vivo against metallo-β-lactamase-producing Enterobacterales.
    Chen F, Bai M, Liu W, Kong H, Zhang T, Yao H, Zhang E, Du J, Qin S.
    Eur J Med Chem; 2021 Nov 15; 224():113702. PubMed ID: 34303873
    [Abstract] [Full Text] [Related]

  • 11. Small Molecule Carboxylates Inhibit Metallo-β-lactamases and Resensitize Carbapenem-Resistant Bacteria to Meropenem.
    Tehrani KHME, Brüchle NC, Wade N, Mashayekhi V, Pesce D, van Haren MJ, Martin NI.
    ACS Infect Dis; 2020 Jun 12; 6(6):1366-1371. PubMed ID: 32227874
    [Abstract] [Full Text] [Related]

  • 12. Structure-guided optimization of 1H-imidazole-2-carboxylic acid derivatives affording potent VIM-Type metallo-β-lactamase inhibitors.
    Yan YH, Li W, Chen W, Li C, Zhu KR, Deng J, Dai QQ, Yang LL, Wang Z, Li GB.
    Eur J Med Chem; 2022 Jan 15; 228():113965. PubMed ID: 34763944
    [Abstract] [Full Text] [Related]

  • 13. 1,2,4-Triazole-3-thione compounds with a 4-ethyl alkyl/aryl sulfide substituent are broad-spectrum metallo-β-lactamase inhibitors with re-sensitization activity.
    Legru A, Verdirosa F, Hernandez JF, Tassone G, Sannio F, Benvenuti M, Conde PA, Bossis G, Thomas CA, Crowder MW, Dillenberger M, Becker K, Pozzi C, Mangani S, Docquier JD, Gavara L.
    Eur J Med Chem; 2021 Dec 15; 226():113873. PubMed ID: 34626878
    [Abstract] [Full Text] [Related]

  • 14. Approved Drugs Containing Thiols as Inhibitors of Metallo-β-lactamases: Strategy To Combat Multidrug-Resistant Bacteria.
    Klingler FM, Wichelhaus TA, Frank D, Cuesta-Bernal J, El-Delik J, Müller HF, Sjuts H, Göttig S, Koenigs A, Pos KM, Pogoryelov D, Proschak E.
    J Med Chem; 2015 Apr 23; 58(8):3626-30. PubMed ID: 25815530
    [Abstract] [Full Text] [Related]

  • 15. The structure of the metallo-β-lactamase VIM-2 in complex with a triazolylthioacetamide inhibitor.
    Christopeit T, Yang KW, Yang SK, Leiros HK.
    Acta Crystallogr F Struct Biol Commun; 2016 Nov 01; 72(Pt 11):813-819. PubMed ID: 27834790
    [Abstract] [Full Text] [Related]

  • 16. Faropenem reacts with serine and metallo-β-lactamases to give multiple products.
    Lucic A, Hinchliffe P, Malla TR, Tooke CL, Brem J, Calvopiña K, Lohans CT, Rabe P, McDonough MA, Armistead T, Orville AM, Spencer J, Schofield CJ.
    Eur J Med Chem; 2021 Apr 05; 215():113257. PubMed ID: 33618159
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and biological evaluation of Aspergillomarasmine A derivatives as novel NDM-1 inhibitor to overcome antibiotics resistance.
    Zhang J, Wang S, Wei Q, Guo Q, Bai Y, Yang S, Song F, Zhang L, Lei X.
    Bioorg Med Chem; 2017 Oct 01; 25(19):5133-5141. PubMed ID: 28784300
    [Abstract] [Full Text] [Related]

  • 18. In Vitro and In Vivo Development of a β-Lactam-Metallo-β-Lactamase Inhibitor: Targeting Carbapenem-Resistant Enterobacterales.
    Peters BK, Reddy N, Shungube M, Girdhari L, Baijnath S, Mdanda S, Chetty L, Ntombela T, Arumugam T, Bester LA, Singh SD, Chuturgoon A, Arvidsson PI, Maguire GEM, Kruger HG, Naicker T, Govender T.
    ACS Infect Dis; 2023 Mar 10; 9(3):486-496. PubMed ID: 36786013
    [Abstract] [Full Text] [Related]

  • 19. Suppression of β-Lactam Resistance by Aspergillomarasmine A Is Influenced by both the Metallo-β-Lactamase Target and the Antibiotic Partner.
    Rotondo CM, Sychantha D, Koteva K, Wright GD.
    Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 31932375
    [Abstract] [Full Text] [Related]

  • 20. Drug Repurposing of the Unithiol: Inhibition of Metallo-β-Lactamases for the Treatment of Carbapenem-Resistant Gram-Negative Bacterial Infections.
    Grigorenko VG, Khrenova MG, Andreeva IP, Rubtsova MY, Lev AI, Novikova TS, Detusheva EV, Fursova NK, Dyatlov IA, Egorov AM.
    Int J Mol Sci; 2022 Feb 06; 23(3):. PubMed ID: 35163756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.